Stay updated on Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.

Latest updates to the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s displayed UI/application revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version tweak rather than a change to the trial record itself.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedAdded Revision: v3.5.0 to the Record History; removed Revision: v3.4.3 from the Record History.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check64 days agoChange DetectedThe new screenshot shows the same record history with updated visual highlighting for additions and deletions; there are no substantive changes to the study data.SummaryDifference0.0%

- Check86 days agoChange DetectedA minor site version update from Revision: v3.4.1 to v3.4.2 is shown; no study data, status, or record content appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.